Literature DB >> 17142786

Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes.

Céline Eidenschenk1, Emmanuelle Jouanguy, Alexandre Alcaïs, Jean-Jacques Mention, Benoit Pasquier, Ingrid M Fleckenstein, Anne Puel, Laure Gineau, Jean-Claude Carel, Eric Vivier, Françoise Le Deist, Jean-Laurent Casanova.   

Abstract

We previously reported the clinical phenotype of two siblings with a novel inherited developmental and immunodeficiency syndrome consisting of severe intrauterine growth retardation and the impaired development of specific lymphoid lineages, including transient CD8 alphabeta T lymphopenia and a persistent lack of blood NK cells. We describe here the elucidation of a plausible underlying pathogenic mechanism, with a cellular phenotype of impaired survival of both fresh and herpesvirus saimiri-transformed T cells, in the surviving child. Clearly, NK cells could not be studied. However, peripheral blood T lymphocytes displayed excessive apoptosis ex vivo. Moreover, the survival rates of CD4 and CD8 alphabeta T cell blasts generated in vitro, and herpesvirus saimiri-transformed T cells cultured in vitro, were low, but not nil, following treatment with IL-2 and IL-15. In contrast, Fas-mediated activation-induced cell death was not enhanced, indicating a selective excess of cytokine deprivation-mediated apoptosis. In keeping with the known roles of IL-2 and IL-15 in the development of NK and CD8 T cells in the mouse model, these data suggest that an impaired, but not abolished, survival response to IL-2 and IL-15 accounts for the persistent lack of NK cells and the transient CD8 alphabeta T lymphopenia documented in vivo. Impaired cytokine-mediated lymphocyte survival is likely to be the pathogenic mechanism underlying this novel form of inherited and selective NK deficiency in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142786     DOI: 10.4049/jimmunol.177.12.8835

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Adaptive immune responses mediated by natural killer cells.

Authors:  Silke Paust; Balimkiz Senman; Ulrich H von Andrian
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 3.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 4.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 5.  Clinical utility of natural killer cells in cancer therapy and transplantation.

Authors:  David A Knorr; Veronika Bachanova; Michael R Verneris; Jeffrey S Miller
Journal:  Semin Immunol       Date:  2014-03-05       Impact factor: 11.130

6.  α2β1 Integrin Is Required for Optimal NK Cell Proliferation during Viral Infection but Not for Acquisition of Effector Functions or NK Cell-Mediated Virus Control.

Authors:  Colby Stotesbury; Pedro Alves-Peixoto; Brian Montoya; Maria Ferez; Savita Nair; Christopher M Snyder; Shunchuan Zhang; Cory J Knudson; Luis J Sigal
Journal:  J Immunol       Date:  2020-02-03       Impact factor: 5.422

Review 7.  Insights into NK cell biology from human genetics and disease associations.

Authors:  Stephanie M Wood; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Cell Mol Life Sci       Date:  2011-08-27       Impact factor: 9.261

8.  Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency.

Authors:  Laure Gineau; Céline Cognet; Nihan Kara; Francis Peter Lach; Jean Dunne; Uma Veturi; Capucine Picard; Céline Trouillet; Céline Eidenschenk; Said Aoufouchi; Alexandre Alcaïs; Owen Smith; Frédéric Geissmann; Conleth Feighery; Laurent Abel; Agata Smogorzewska; Bruce Stillman; Eric Vivier; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

Review 9.  The Impact of Immunodeficiency on NK Cell Maturation and Function.

Authors:  Alexander Vargas-Hernández; Lisa R Forbes
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-19       Impact factor: 4.806

Review 10.  Inborn errors of the development of human natural killer cells.

Authors:  Emmanuelle Jouanguy; Laure Gineau; Julien Cottineau; Vivien Béziat; Eric Vivier; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.